137.2K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Werner Cautreels | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 18 Feb 2025 | 96,348 | 104,348 (0%) | 0% | 0.0 | 963 | Common Stock |
| Werner Cautreels | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 96,348 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
| Werner Cautreels | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Series A Warrant (right to buy) | |
| Werner Cautreels | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Pre-Funded Warrant (right to buy) | |
| Nikolay Savchuk | Director, Chief Operating Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Pre-Funded Warrant (right to buy) | |
| Nikolay Savchuk | Director, Chief Operating Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Series A Warrant (right to buy) | |
| Mark P. Guerin | CFO | 10 Jun 2024 | 5,500 | 5,500 | - | - | Restricted Stock Units | ||
| Mark P. Guerin | CFO | 10 Jun 2024 | 2,221 | 39,255 (0%) | 0% | 0.5 | 1,044 | Common Stock | |
| Mark P. Guerin | CFO | 10 Jun 2024 | 5,500 | 41,476 (0%) | 0% | - | Common Stock | ||
| Robert Redfield | Acting Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 97,500 | 97,500 (0%) | 0% | - | Common Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 66,687 | 66,687 (0%) | 0% | - | Common Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 67,550 | 134,187 (0%) | 0% | - | Common Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 885,532 | 885,532 (0%) | 0% | - | Common Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 1,645,100 | 1,645,100 (1%) | 1% | - | Common Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,802,890 | 3,802,890 | - | - | Stock Option (right to purchase) | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 194 | 194 | - | - | Series C Preferred Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 2,584 | 2,584 | - | - | Series C Preferred Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 4,801 | 4,801 | - | - | Series C Preferred Stock | |
| Charles David Pauza | Chief Science Officer Virology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 97,500 | 97,500 (0%) | 0% | - | Common Stock | |
| Charles David Pauza | Chief Science Officer Virology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 333,136 | 333,136 | - | - | Stock Option (right to purchase) | |
| Charles David Pauza | Chief Science Officer Virology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 503,227 | 503,227 | - | - | Stock Option (right to purchase) | |
| Werner Cautreels | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 200,000 | 200,000 (0%) | 0% | - | Common Stock | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 4,801 | 4,801 | - | - | Series C Preferred Stock | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 66,687 | 66,687 (0%) | 0% | - | Common Stock | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,802,890 | 3,802,890 | - | - | Stock Option (right to purchase) | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 1,645,100 | 1,645,100 (1%) | 1% | - | Common Stock | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 67,550 | 134,187 (0%) | 0% | - | Common Stock | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 194 | 194 | - | - | Series C Preferred Stock | |
| Iain D. Dukes | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 67,500 | 134,187 (0%) | 0% | - | Common Stock | |
| Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 67,500 | 134,187 (0%) | 0% | - | Common Stock | |
| Mark P. Guerin | CFO AND COO | 13 Mar 2024 | 8,666 | 38,567 (0%) | 0% | - | Common Stock | ||
| Mark P. Guerin | CFO AND COO | 13 Mar 2024 | 8,666 | 17,334 | - | - | Restricted Stock Units | ||
| Mark P. Guerin | CFO AND COO | 13 Mar 2024 | 2,591 | 35,976 (0%) | 0% | 0.9 | 2,332 | Common Stock | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 23,111 | 83,519 (0%) | 0% | - | Common Stock | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 13 Mar 2024 | 8,727 | 74,792 (0%) | 0% | 0.9 | 7,854 | Common Stock |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 23,111 | 46,222 | - | - | Restricted Stock Units | |
| P. Mark Guerin | CFO AND COO | 07 Feb 2024 | 2,443 | 29,901 (0%) | 0% | 0.7 | 1,637 | Common Stock | |
| P. Mark Guerin | CFO AND COO | 07 Feb 2024 | 6,900 | 32,344 (0%) | 0% | - | Common Stock | ||
| Steven Fruchtman M. | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 21,320 | 21,320 | - | - | Restricted Stock Units | |
| M. Fruchtman Steven | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 07 Feb 2024 | 9,212 | 60,408 (0%) | 0% | 0.7 | 6,172 | Common Stock |
| Fruchtman Steven M. | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 21,320 | 69,620 (0%) | 0% | - | Common Stock | |
| Guerin P. Mark | CFO AND COO | 07 Feb 2024 | 6,900 | 6,900 | - | - | Restricted Stock Units | ||
| Jack E. Stover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Mary Teresa Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Peter Atadja | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Mark P. Guerin | CFO AND COO | 02 Aug 2023 | 1,422 | 25,444 (0%) | 0% | 1.0 | 1,450 | Common Stock | |
| Mark P. Guerin | CFO AND COO | 02 Aug 2023 | 4,750 | 4,750 | - | - | Restricted Stock Units | ||
| Mark P. Guerin | CFO AND COO | 02 Aug 2023 | 4,750 | 26,866 (0%) | 0% | - | Common Stock | ||
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 02 Aug 2023 | 4,744 | 48,300 (0%) | 0% | 1.0 | 4,791 | Common Stock |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 12,567 | 12,567 | - | - | Restricted Stock Units | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 12,567 | 53,044 (0%) | 0% | - | Common Stock | |
| Mark P. Guerin | CFO AND COO | 12 Jun 2023 | 5,500 | 23,691 (0%) | 0% | - | Common Stock | ||
| Mark P. Guerin | CFO AND COO | 12 Jun 2023 | 1,575 | 22,116 (0%) | 0% | 1.1 | 1,791 | Common Stock | |
| Mark P. Guerin | CFO AND COO | 12 Jun 2023 | 5,500 | 11,000 | - | - | Restricted Stock Units | ||
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 62,000 | 62,000 | - | - | Stock Option (right to purchase) | |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 20,667 | 20,667 | - | - | Restricted Stock Units | |
| Mark P. Guerin | CFO AND COO | 13 Mar 2023 | 26,000 | 26,000 | - | - | Restricted Stock Units | ||
| Mark P. Guerin | CFO AND COO | 13 Mar 2023 | 79,000 | 79,000 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 69,333 | 69,333 | - | - | Restricted Stock Units | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 207,000 | 207,000 | - | - | Stock Option (right to purchase) | |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 5,833 | 11,729 (0%) | 0% | - | Common Stock | |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 5,833 | 11,667 | - | - | Restricted Stock Units | |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.36 per share. | 07 Feb 2023 | 1,242 | 10,487 (0%) | 0% | 1.4 | 1,689 | Common Stock |
| Mark P. Guerin | CFO AND COO | 07 Feb 2023 | 6,900 | 13,800 | - | - | Restricted Stock Units | ||
| Mark P. Guerin | CFO AND COO | 07 Feb 2023 | 1,785 | 18,191 (0%) | 0% | 1.4 | 2,428 | Common Stock | |
| Mark P. Guerin | CFO AND COO | 07 Feb 2023 | 6,900 | 19,976 (0%) | 0% | - | Common Stock | ||
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.36 per share. | 07 Feb 2023 | 6,977 | 40,477 (0%) | 0% | 1.4 | 9,489 | Common Stock |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 21,320 | 42,640 | - | - | Restricted Stock Units | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 21,320 | 47,454 (0%) | 0% | - | Common Stock | |
| Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 100,000 | 100,000 | - | - | Stock Option (right to purchase) | |
| Peter Atadja | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 100,000 | 100,000 | - | - | Stock Option (right to purchase) | |
| Jack E. Stover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Mary Teresa Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Aug 2022 | 1,135 | 5,896 (0%) | 0% | 1.3 | 1,498 | Common Stock |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 4,650 | 9,300 | - | - | Restricted Stock Units | |
| Mark S. Gelder | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 4,650 | 7,031 (0%) | 0% | - | Common Stock | |
| Mark Guerin | CFO AND COO | 02 Aug 2022 | 1,355 | 13,076 (0%) | 0% | 1.3 | 1,789 | Common Stock | |
| Mark Guerin | CFO AND COO | 02 Aug 2022 | 4,750 | 14,431 (0%) | 0% | - | Common Stock | ||
| Mark Guerin | CFO AND COO | 02 Aug 2022 | 4,750 | 9,500 | - | - | Restricted Stock Units | ||
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 12,566 | 30,696 (0%) | 0% | - | Common Stock | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 12,566 | 25,134 | - | - | Restricted Stock Units | |
| Steven M. Fruchtman | Director, PRESIDENT, CHIEF EXECUTIVE OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 02 Aug 2022 | 4,562 | 26,134 (0%) | 0% | 1.3 | 6,022 | Common Stock |
| Mark Guerin | COO and CFO | 10 Jun 2022 | 50,250 | 50,250 | - | - | Stock Option (right to purchase) | ||
| Mark Guerin | COO and CFO | 10 Jun 2022 | 16,500 | 16,500 | - | - | Restricted Stock Units | ||
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 17,633 | 17,633 | - | - | Restricted Stock Units | |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 54,050 | 54,050 | - | - | Stock Option (right to purchase) | |
| Mark S. Gelder | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 51,750 | 51,750 | - | - | Stock Option (right to purchase) | |
| Mark S. Gelder | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 17,500 | 17,500 | - | - | Restricted Stock Units | |
| Mark Guerin | Chief Financial Officer | 07 Feb 2022 | 20,700 | 20,700 | - | - | Restricted Stock Units | ||
| Mark Guerin | Chief Financial Officer | 07 Feb 2022 | 62,100 | 62,100 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 63,960 | 63,960 | - | - | Restricted Stock Units | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 191,880 | 191,880 | - | - | Stock Option (right to purchase) | |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 28 Jan 2022 | 1,500 | 24,514 (0%) | 0% | 1.7 | 2,505 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 21 Jan 2022 | 1,500 | 23,014 (0%) | 0% | 2.0 | 3,030 | Common Stock |
| Abraham N. Oler | SVP CORP DEV & GEN COUNSEL | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 14 Jan 2022 | 1,500 | 21,514 (0%) | 0% | 2.2 | 3,300 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 2.39 per share. | 07 Jan 2022 | 1,500 | 20,014 (0%) | 0% | 2.4 | 3,585 | Common Stock |
| Abraham N. Oler | SVP CORP DEV & GEN COUNSEL | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 19 Nov 2021 | 1,000 | 18,514 (0%) | 0% | 3.2 | 3,160 | Common stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | 18 Nov 2021 | 5,000 | 0 | - | - | Warrant (right to purchase) | ||
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | 18 Nov 2021 | 5,000 | 17,514 (0%) | 0% | 3 | 15,000 | Common Stock | |
| James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 28 Sep 2021 | 5,952 | 21,334 (0%) | 0% | 4.2 | 24,998 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 28 Sep 2021 | 2,381 | 12,515 (0%) | 0% | 4.2 | 10,000 | Common Stock |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 28 Sep 2021 | 2,381 | 18,130 (0%) | 0% | 4.2 | 10,000 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 40,000 | 40,000 | - | - | Stock Option (right to purchase) | |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 13,400 | 13,400 | - | - | Restricted Stock Units | |
| Mark Guerin | Chief Financial Officer | 02 Aug 2021 | 42,750 | 42,750 | - | - | Stock Option (right to purchase) | ||
| Mark Guerin | Chief Financial Officer | 02 Aug 2021 | 14,250 | 14,250 | - | - | Restricted Stock Units | ||
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 37,700 | 37,700 | - | - | Restricted Stock Unit | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 113,000 | 113,000 | - | - | Stock Option (right to purchase) | |
| James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Mary Teresa Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 208,000 | 208,000 | - | - | Stock Appreciation Right | |
| Mark Guerin | Chief Financial Officer | 17 Feb 2021 | 301,000 | 301,000 | - | - | Stock Appreciation Right | ||
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 706,000 | 706,000 | - | - | Stock Appreciation Right | |
| James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 16 Feb 2021 | 25,000 | 230,716 (0%) | 0% | 1 | 25,000 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 16 Feb 2021 | 12,000 | 152,000 (0%) | 0% | 1 | 12,000 | Common Stock |
| Mark Guerin | Chief Financial Officer | 16 Feb 2021 | 15,000 | 145,213 (0%) | 0% | 1 | 15,000 | Common Stock | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 16 Feb 2021 | 20,000 | 236,226 (0%) | 0% | 1 | 20,000 | Common Stock |
| Mary Teresa Shoemaker | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 16 Feb 2021 | 13,000 | 50,735 (0%) | 0% | 1 | 13,000 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 0.32 per share. | 11 Dec 2020 | 30,000 | 140,000 (0%) | 0% | 0.3 | 9,600 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 0.26 per share. | 25 Nov 2020 | 20,000 | 110,000 (0%) | 0% | 0.3 | 5,120 | Common Stock |
| Mark Guerin | Chief Financial Officer | 25 Nov 2020 | 4,614 | 130,213 (0%) | 0% | 0.3 | 1,200 | Common Stock | |
| Mark Guerin | Chief Financial Officer | 25 Nov 2020 | 16,755 | 125,599 (0%) | 0% | 0.3 | 4,356 | Common Stock | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 0.26 per share. | 25 Nov 2020 | 40,000 | 216,226 (0%) | 0% | 0.3 | 10,360 | Common Stock |
| Mary Teresa Shoemaker | Director | Purchase of securities on an exchange or from another person at price $ 0.27 per share. | 25 Nov 2020 | 37,735 | 37,735 (0%) | 0% | 0.3 | 10,000 | Common Stock |
| James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 0.26 per share. | 24 Nov 2020 | 38,774 | 205,716 (0%) | 0% | 0.3 | 10,004 | Common Stock |
| Michael M.B. Hoffman | Director | Sale of securities on an exchange or to another person at price $ 0.27 per share. | 27 Aug 2020 | 182,492 | 21,919 (0%) | 0% | 0.3 | 49,620 | Common Stock |
| Michael M.B. Hoffman | Director | Sale of securities on an exchange or to another person at price $ 0.27 per share. | 27 Aug 2020 | 1,876 | 0 (0%) | 0% | 0.3 | 510 | Common Stock |
| E. Premkumar Reddy | Director | Sale of securities on an exchange or to another person at price $ 0.27 per share. | 27 Aug 2020 | 527,863 | 16,683 (0%) | 0% | 0.3 | 143,948 | Common Stock |
| Jack E. Stover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Michael M.B. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Viren Mehta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Jerome E. Groopman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 375,600 | 375,600 | - | - | Stock Appreciation Right | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 418,600 | 418,600 | - | - | Stock Appreciation Right | |
| E. Premkumar Reddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Mark Guerin | Chief Financial Officer | 09 Jul 2020 | 543,000 | 543,000 | - | - | Stock Appreciation Right | ||
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 1,273,800 | 1,273,800 | - | - | Stock Appreciation Right | |
| Richard Charles Woodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 396,000 | 396,000 | - | - | Stock Appreciation Right | |
| Mary Teresa Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Jerome E. Groopman | Director | Purchase of securities on an exchange or from another person at price $ 0.36 per share. | 19 May 2020 | 10,000 | 10,001 (0%) | 0% | 0.4 | 3,626 | Common Stock |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 19 May 2020 | 15,000 | 90,000 (0%) | 0% | 0.4 | 5,550 | Common Stock |
| Mark Guerin | Chief Financial Officer | 19 May 2020 | 21,000 | 108,844 (0%) | 0% | 0.4 | 7,560 | Common Stock | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 19 May 2020 | 26,800 | 176,226 (0%) | 0% | 0.4 | 9,857 | Common Stock |
| Abraham N. Oler | VP Corp Dev & Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2019 | 60,000 | 60,000 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2019 | 43,000 | 43,000 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Financial Officer | 20 Dec 2019 | 65,000 | 65,000 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Director, President, Chief Executive Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2019 | 200,000 | 200,000 | - | - | Stock Option (right to purchase) | |
| Richard Charles Woodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2019 | 80,000 | 80,000 | - | - | Stock Option (right to purchase) | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2019 | 150,000 | 150,000 | - | - | Warrant (right to purchase) | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Nov 2019 | 150,000 | 166,942 (0%) | 0% | 0.2 | 30,000 | Common Stock |
| Viren Mehta | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2019 | 250,000 | 250,000 | - | - | Warrant (right to purchase) | |
| Viren Mehta | None | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Nov 2019 | 250,000 | 250,857 (0%) | 0% | 0.2 | 50,000 | Common Stock |
| Abraham N. Oler | VP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Nov 2019 | 75,000 | 75,000 (0%) | 0% | 0.2 | 15,000 | Common Stock |
| Abraham N. Oler | VP Corp Dev & Gen Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2019 | 75,000 | 75,000 | - | - | Warrant (right to purchase) | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2019 | 500,000 | 500,000 | - | - | Warrant (right to purchase) | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Nov 2019 | 500,000 | 544,546 (1%) | 1% | 0.2 | 100,000 | Common Stock |
| Mark Guerin | Chief Financial Officer | 25 Nov 2019 | 87,500 | 87,500 | - | - | Warrant (right to purchase) | ||
| Mark Guerin | Chief Financial Officer | 25 Nov 2019 | 87,500 | 87,844 (0%) | 0% | 0.2 | 17,500 | Common Stock | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Sep 2019 | 1,472 | 1,472 | - | - | Warrant (right to purchase) | |
| James J. Marino | None | 25 Sep 2019 | 5,000 | 0 | - | - | Warrant (right to purchase) | ||
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 25 Sep 2019 | 7,260 | 16,942 (0%) | 0% | 1.6 | 11,616 | Common Stock |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Sep 2019 | 5,000 | 5,000 | - | - | Warrant (right to purchase) | |
| James J. Marino | None | 25 Sep 2019 | 1,472 | 0 | - | - | Warrant (right to purchase) | ||
| Jack E. Stover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 5,833 | 5,833 | - | - | Stock Option (right to purchase) | |
| James J. Marino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 5,833 | 5,833 | - | - | Stock Option (right to purchase) | |
| Michael M.B. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 5,833 | 5,833 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 5,833 | 5,833 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 5,833 | 5,833 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 5,833 | 5,833 | - | - | Stock Option (right to purchase) | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2019 | 149,000 | 149,000 | - | - | Warrant (right to purchase) | |
| Steven M. Fruchtman | Director, President, Chief Executive Off | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Jan 2019 | 149,000 | 149,426 (0%) | 0% | 0.2 | 29,800 | Common Stock |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2018 | 5,000 | 5,000 | - | - | Stock Option (right to purchase) | |
| Richard Charles Woodman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2018 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Michael M.B. Hoffman | None | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 27 Aug 2018 | 29,999 | 5,731,116 (6%) | 0% | 0.5 | 13,521 | Common Stock |
| Michael M.B. Hoffman | None | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 27 Aug 2018 | 20,000 | 5,811,116 (6%) | 0% | 0.5 | 9,070 | Common Stock |
| Michael M.B. Hoffman | None | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 27 Aug 2018 | 20,000 | 5,791,116 (6%) | 0% | 0.4 | 8,890 | Common Stock |
| Michael M.B. Hoffman | None | Sale of securities on an exchange or to another person at price $ 0.46 per share. | 27 Aug 2018 | 30,000 | 5,761,116 (6%) | 0% | 0.5 | 13,707 | Common Stock |
| Jack E. Stover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| James J. Marino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| Michael M.B. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 1,065,600 | 1,065,600 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 300,000 | 300,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Financial Officer | 26 Jul 2018 | 384,950 | 384,950 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | President, Chief Medical Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2018 | 400,000 | 400,000 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 29 May 2018 | 10,000 | 22,724 (0%) | 0% | 0.4 | 3,800 | Common Stock |
| Jack E. Stover | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 47,100 | 47,110 (0%) | 0% | 0 | Common Stock | |
| Jack E. Stover | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 47,100 | 47,100 | - | - | Warrant (right to purchase) | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 58,900 | 58,900 | - | - | Warrant (right to purchase) | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 58,900 | 145,221 (0%) | 0% | 0 | Common Stock | |
| Michael M.B. Hoffman | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 2,211,765 | 2,211,765 | - | - | Warrant (right to purchase) | |
| Michael M.B. Hoffman | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 2,211,765 | 3,192,438 (15%) | 10% | 0 | Common Stock | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 282,350 | 668,182 (3%) | 1% | 0 | Common Stock | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Apr 2018 | 282,350 | 282,350 | - | - | Warrant (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2018 | 73,220 | 73,220 | - | - | Stock Option (right to purchase) | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Feb 2018 | 50,000 | 86,321 (0%) | 0% | 0 | Common Stock | |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Feb 2018 | 50,000 | 50,000 | - | - | Warrant (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 64,885 | 64,885 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 28,609 | 28,609 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Financial Officer | 03 Jan 2018 | 31,024 | 31,024 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 43,627 | 43,627 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 1,500 | 1,500 | - | - | Stock Option (right to purchase) | |
| Jack E. Stover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 1,500 | 1,500 | - | - | Stock Option (right to purchase) | |
| James J. Marino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 1,500 | 1,500 | - | - | Stock Option (right to purchase) | |
| Michael M.B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 2,000 | 2,000 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 1,500 | 1,500 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 1,500 | 1,500 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 1,500 | 1,500 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 26 Apr 2017 | 3,810 | 12,724 (0%) | 0% | 2.1 | 8,001 | Common Stock |
| James J. Marino | None | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 26 Apr 2017 | 11,906 | 36,321 (0%) | 0% | 2.1 | 25,003 | Common Stock |
| Ramesh Kumar | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 26 Apr 2017 | 23,810 | 102,227 (1%) | 0% | 2.1 | 50,001 | Common Stock |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 26 Apr 2017 | 119,048 | 385,832 (4%) | 1% | 2.1 | 250,001 | Common Stock |
| Mark Guerin | Chief Financial Officer | 26 Apr 2017 | 1,429 | 5,155 (0%) | 0% | 2.1 | 3,001 | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2017 | 44,027 | 44,027 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2017 | 19,413 | 19,413 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Financial Officer | 17 Jan 2017 | 19,413 | 19,413 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2017 | 26,401 | 26,401 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 12,673 | 12,673 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 5,587 | 5,587 | - | - | Stock Option | |
| Mark Guerin | Chief Financial Officer | 15 Dec 2016 | 5,587 | 5,587 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2016 | 7,599 | 7,599 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2016 | 44,000 | 44,000 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2016 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Mark Guerin | Chief Financial Officer | 01 Sep 2016 | 5,000 | 5,000 | - | - | Stock Option (right to purchase) | ||
| Mark Guerin | Chief Financial Officer | 01 Sep 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2016 | 25,000 | 25,000 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | 26 Jul 2016 | 5,564 | 5,564 | - | - | Warrants (right to buy) | ||
| Henry S. Bienen | None | 26 Jul 2016 | 7,420 | 8,914 | - | - | Common Stock | ||
| Henry S. Bienen | None | 26 Jul 2016 | 2,241 | 0 | - | - | Subscription Rights (right to buy) | ||
| James J. Marino | None | 26 Jul 2016 | 18,303 | 18,303 | - | - | Warrants (right to buy) | ||
| James J. Marino | None | 26 Jul 2016 | 24,405 | 24,415 | - | - | Common Stock | ||
| James J. Marino | None | 26 Jul 2016 | 15 | 0 | - | - | Subscription Rights (right to buy) | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 26 Jul 2016 | 528,845 | 0 | - | - | Subscription Rights (right to buy) | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 26 Jul 2016 | 396,633 | 396,633 | - | - | Warrants (right to buy) | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 26 Jul 2016 | 528,845 | 980,673 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 26 Jul 2016 | 41,475 | 0 | - | - | Subscription Right (right to buy) | ||
| Ramesh Kumar | Director, President and CEO | 26 Jul 2016 | 50,765 | 78,417 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 26 Jul 2016 | 38,071 | 38,071 | - | - | Warrants (right to buy) | ||
| E. Premkumar Reddy | None | 26 Jul 2016 | 99,750 | 99,750 | - | - | Warants (right to buy) | ||
| E. Premkumar Reddy | None | 26 Jul 2016 | 133,000 | 266,784 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 26 Jul 2016 | 133,000 | 0 | - | - | Subscription Rights (right to receive) | ||
| Mark Guerin | Chief Accounting Officer | 26 Jul 2016 | 3,666 | 3,726 | - | - | Common Stock | ||
| Mark Guerin | Chief Accounting Officer | 26 Jul 2016 | 2,749 | 2,749 | - | - | Warrants (right to buy) | ||
| Mark Guerin | Chief Accounting Officer | 26 Jul 2016 | 90 | 0 | - | - | Subscription Rights (right to buy) | ||
| Steven M. Fruchtman | Chief Medical Officer | 26 Jul 2016 | 6,276 | 6,376 | - | - | Common Stock | ||
| Steven M. Fruchtman | Chief Medical Officer | 26 Jul 2016 | 4,706 | 4,706 | - | - | Warrants (right to buy) | ||
| Steven M. Fruchtman | Chief Medical Officer | 26 Jul 2016 | 150 | 0 | - | - | Subscription Rights(right to buy) | ||
| Manoj Maniar | SVP - Product Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2016 | 50 | 50 | - | - | Common Stock | |
| Manoj Maniar | SVP - Product Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2016 | 50 | 10,342 | - | - | Stock Option (right to buy) | |
| Jerome E. Groopman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2016 | 10 | 990 | - | - | Stock Option (right to buy) | |
| Jerome E. Groopman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2016 | 10 | 10 | - | - | Common Stock | |
| James J. Marino | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2016 | 10 | 10 | - | - | Common Stock | |
| James J. Marino | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2016 | 10 | 990 | - | - | Stock Option (right to buy) | |
| Steven M. Fruchtman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2016 | 100 | 12,411 | - | - | Stock Option (right to buy) | |
| Steven M. Fruchtman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2016 | 100 | 100 | - | - | Common Stock | |
| Henry S. Bienen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Jack E. Stover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Jack E. Stover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| James J. Marino | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Michael B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 69,984 | 69,984 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 71,029 | 71,029 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 146,440 | 146,440 | - | - | Stock Option (right to buy) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 103,918 | 103,918 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Accounting Officer | 26 Jan 2016 | 46,809 | 46,809 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 125,107 | 125,107 | - | - | Stock Option (right to purchase) | |
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2015 | 32,500 | 32,500 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2015 | 37,500 | 37,500 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2015 | 87,500 | 87,500 | - | - | Stock Option (right to purchase) | |
| Manoj Maniar | SVP - Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2015 | 40,000 | 40,000 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Accounting Officer | 25 Sep 2015 | 17,500 | 17,500 | - | - | Stock Option (right to purchase) | ||
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2015 | 40,000 | 40,000 | - | - | Stock Option (right to purchase) | |
| Anne M. Vanlent | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Michael B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2015 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Steven M. Fruchtman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2015 | 35,000 | 35,000 | - | - | Stock Option (right to purchase) | |
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2015 | 32,500 | 32,500 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2015 | 37,500 | 37,500 | - | - | Stock Option (right to buy) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2015 | 87,500 | 87,500 | - | - | Stock Option (right to buy) | |
| Mark Guerin | Chief Accounting Officer | 16 Apr 2015 | 15,000 | 15,000 | - | - | Stock Option (right ot purchase) | ||
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2014 | 65,000 | 65,000 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2014 | 75,000 | 75,000 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2014 | 175,000 | 175,000 | - | - | Stock Option (right to purchase) | |
| Mark Guerin | Chief Accounting Officer | 18 Dec 2014 | 25,000 | 25,000 | - | - | Stock Option (right to purchase) | ||
| Michael B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2014 | 18,754 | 18,754 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2014 | 18,754 | 0 | - | - | Stock Option (right to purchase) | |
| Anne M. Vanlent | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Michael B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2014 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2014 | 27,084 | 1,337,838 | - | - | Common Stock | |
| E. Premkumar Reddy | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2014 | 27,084 | 0 | - | - | Common Stock Option (right to buy) | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Feb 2014 | 71,740 | 4,446,535 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Feb 2014 | 71,740 | 4,518,275 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 276,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 296,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 276,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 296,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 276,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 5,256 | 0 | - | - | Stock Option (right to buy) | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 5,256 | 281,756 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 14,744 | 296,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 50,282 | - | - | Stock Option (right to buy) | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 20,000 | 70,282 | - | - | Stock Option (right to buy) | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2014 | 14,744 | 90,282 | - | - | Stock Option (right to buy) | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2014 | 31,706 | 4,349,206 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2014 | 25,589 | 4,374,795 | - | - | Common Stock | |
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 65,000 | 65,000 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 72,000 | 72,000 | - | - | Stock Option (right to purchase) | |
| James Altland | SVP, Finance & Corp. Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 12,000 | 12,000 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2013 | 135,000 | 135,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2013 | 32,036 | 1,310,754 | - | - | Common Stock | |
| E. Premkumar Reddy | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2013 | 32,036 | 0 | - | - | Common Stock Option (right to buy) | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2013 | 4,900 | 4,317,500 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2013 | 100 | 4,312,600 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2013 | 5,000 | 4,312,500 | - | - | Common Stock | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2013 | 5,000 | 1,278,718 | - | - | Common Stock | |
| Henry S. Bienen | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 1,248 | 14,783 | - | - | Common Stock | |
| Henry S. Bienen | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 152 | 14,935 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 7,800 | 4,307,500 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 1,900 | 4,299,700 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 5,000 | 4,297,800 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 5,000 | 4,292,800 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Nov 2013 | 1,100 | 276,500 | - | - | Common Stock | |
| Ajay Bansal | Chief Financial Officer | 30 Jul 2013 | 23,785 | 43,846 | - | - | Common Stock | ||
| Ajay Bansal | Chief Financial Officer | 30 Jul 2013 | 28,181 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Henry S. Bienen | None | 30 Jul 2013 | 6,868 | 6,868 | - | - | Common Stock | ||
| Henry S. Bienen | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2013 | 6,667 | 13,535 | - | - | Common Stock | |
| Henry S. Bienen | None | 30 Jul 2013 | 9,156 | 0 | - | - | Series I Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 229,825 | 0 | - | - | Series G Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2013 | 1,000,000 | 4,372,330 | - | - | Common Stock | |
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 1,226,942 | 3,372,330 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 226,024 | 2,145,388 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 172,411 | 1,919,364 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 84,530 | 1,746,953 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 85,744 | 1,662,423 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 476,087 | 1,576,679 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 266,712 | 1,100,592 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 105,363 | 833,880 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 83,857 | 728,517 | - | - | Common Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 99,350 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 140,449 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 355,528 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 634,625 | 0 | - | - | Series E Covertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 111,227 | 109,653 | - | - | Series F Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 109,653 | 0 | - | - | Series F Convertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 301,290 | 0 | - | - | Series H COnvertible Preferred Stock | ||
| Michael B. Hoffman | Director, Ten Percent Owner | 30 Jul 2013 | 1,635,514 | 0 | - | - | Series I Convertible Preferred Stock | ||
| Thomas Mckearn | President, R&D | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2013 | 3,333 | 3,333 | - | - | Common Stock | |
| Viren Mehta | None | 30 Jul 2013 | 73,839 | 85,479 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 87,470 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 10,246 | 0 | - | - | Series E Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 22,771 | 0 | - | - | Series I Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 8,020 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 1,030 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 1,007 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 5,488 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 2,270 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 2,296 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 1,245 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 460 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 451 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 7,686 | 93,165 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 17,082 | 110,247 | - | - | Common Stock | ||
| Viren Mehta | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2013 | 16,667 | 126,914 | - | - | Common Stock | |
| Viren Mehta | None | 30 Jul 2013 | 6,768 | 6,768 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 772 | 7,540 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 755 | 8,295 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 4,632 | 4,632 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 1,702 | 6,334 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 1,722 | 8,056 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 1,050 | 1,050 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 345 | 1,395 | - | - | Common Stock | ||
| Viren Mehta | None | 30 Jul 2013 | 338 | 1,733 | - | - | Common Stock | ||
| James Altland | SVP, Finance & Corp. Develop. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 5,000 | 5,000 | - | - | Common Stock | |
| James Altland | SVP, Finance & Corp. Develop. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 5,000 | 55,015 | - | - | Stock Option (right to purchase) | |
| James Altland | SVP, Finance & Corp. Develop. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 5,000 | 50,015 | - | - | Stock Option (right to purchase) | |
| James Altland | SVP, Finance & Corp. Develop. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 5,000 | 10,000 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 573 | 268,283 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 375 | 268,658 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 75 | 268,733 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2013 | 6,667 | 275,400 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 20,645 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 983 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 2,209 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 1,084 | 0 | - | - | Series E Covertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 500 | 0 | - | - | Series F Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 765 | 0 | - | - | Series G Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 500 | 0 | - | - | Series H COnvertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 100 | 0 | - | - | Series I Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 4,667 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 3,748 | 246,696 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 737 | 264,857 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 17,424 | 264,120 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 1,657 | 266,514 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 811 | 267,325 | - | - | Common Stock | ||
| Ramesh Kumar | Director, President and CEO | 30 Jul 2013 | 385 | 267,710 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 22,093 | 0 | - | - | Series D Convertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 13,923 | 1,201,548 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 19,569 | 1,221,117 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 737 | 1,221,854 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 16,573 | 1,238,427 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 3,842 | 1,242,269 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 7,708 | 1,249,977 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 1,225 | 1,251,202 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 766 | 1,251,968 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 750 | 1,252,718 | - | - | Common Stock | ||
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2013 | 20,000 | 1,272,718 | - | - | Common Stock | |
| E. Premkumar Reddy | None | 30 Jul 2013 | 1,001 | 0 | - | - | Series I Convertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 1,022 | 0 | - | - | Series H COnvertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 1,634 | 0 | - | - | Series G Convertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 10,000 | 0 | - | - | Series F Convertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 5,124 | 0 | - | - | Series E Covertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 983 | 0 | - | - | Series C Convertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 23,187 | 0 | - | - | Series B Convertible Preferred Stock | ||
| E. Premkumar Reddy | None | 30 Jul 2013 | 17,333 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Anne M. Vanlent | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Anne M. Vanlent | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 40,000 | 40,000 | - | - | Stock Option (right to purchase) | |
| Ajay Bansal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 5,000 | 5,000 | - | - | Stock Option (right to purchase) | |
| Henry S. Bienen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 10,000 | 10,000 | - | - | Stock Option (right to purchase | |
| Michael B. Hoffman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 5,000 | 5,000 | - | - | Stock Option (right to purchase) | |
| Thomas Mckearn | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 30,000 | 30,000 | - | - | Stock Option (right to purchase) | |
| Viren Mehta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 20,000 | 20,000 | - | - | Stock Option (right to purchase) | |
| Jerome E. Groopman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| James Altland | SVP, Finance & Corp. Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 2,500 | 2,500 | - | - | Stock Option (right to purchase) | |
| James Altland | SVP, Finance & Corp. Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 10,000 | 10,000 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 100,000 | 100,000 | - | - | Stock Option (right to purchase) | |
| Ramesh Kumar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 5,000 | 5,000 | - | - | Stock Option (right to purchase) | |
| E. Premkumar Reddy | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2013 | 10,000 | 10,000 | - | - | Stock Option | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jul 2013 | 700 | 1,273,718 | - | - | Common Stock | |
| E. Premkumar Reddy | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jul 2013 | 300 | 1,273,018 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2013 | 13,543 | 290,043 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Feb 2013 | 20,000 | 276,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Feb 2013 | 13,543 | 276,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2013 | 20,000 | 296,500 | - | - | Common Stock | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2013 | 13,543 | 36,739 | - | - | Stock Option (right to buy) | |
| Ramesh Kumar | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2013 | 20,000 | 16,739 | - | - | Stock Option (right to buy) |